Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures
Authors
Keywords
Direct oral anticoagulants, Low bleeding risk procedures, Bleeding, Thromboembolism
Journal
THROMBOSIS RESEARCH
Volume 203, Issue -, Pages 27-32
Publisher
Elsevier BV
Online
2021-04-20
DOI
10.1016/j.thromres.2021.04.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
- (2019) James D. Douketis et al. JAMA Internal Medicine
- Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
- (2018) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the “Real-World” Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials
- (2018) Andrew B. Hughey et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Peri-Procedural Management of Oral Anticoagulants in the DOAC Era
- (2018) Geoffrey D. Barnes et al. PROGRESS IN CARDIOVASCULAR DISEASES
- 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation
- (2017) John U. Doherty et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
- (2017) Hugh Calkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants
- (2016) Prajwal Dhakal et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis
- (2015) Wengen Zhu et al. CLINICAL CARDIOLOGY
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- (2015) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
- (2015) S. Kaatz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
- (2015) James D. Douketis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
- (2014) D. Garcia et al. BLOOD
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
- (2013) David H. Birnie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
- (2012) Geoffrey D. Barnes et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started